Vascular Technology

What Vascular Technology does

Vascular Technology, Incorporated (VTI), headquartered in Nashua, New Hampshire, is a U.S. medical device manufacturer specializing in intraoperative Doppler ultrasound systems and robotic suction irrigation technology used in hospital operating rooms. The company was founded in 1985 (per firmographic data; one secondary source dates operations to approximately 1993), operates with 51-100 employees, and holds ISO 13485 certification and FDA registration, with all products manufactured in the United States. VTI markets its products under the brand 'VTI' across more than 30 years of operating history.

VTI's product portfolio comprises four core Doppler platforms — the 8 MHz TQI 2.0 (Trans-Q-Taneous) system for intraoperative and transcutaneous vessel assessment, the 20 MHz Microvascular system for microvascular interrogation in microsurgery, the 20 MHz Selectable Depth system for endoscopic GI bleeding management, and the flexible Drop-In Doppler probe designed for robotic surgery — alongside the ROSI (Remotely Operated Suction Irrigation) system that gives robotic surgeons console-level control of suction and irrigation with interchangeable rigid and flexible tips. A recurring consumables stream of sterile, single-use disposable Doppler probes (sold in boxes of 4 across multiple specialty configurations and frequencies) supports the installed base of capital equipment and meets Medicare separately billable criteria.

VTI generates revenue primarily through direct enterprise field sales to hospitals and surgical centers under quote-based pricing, complemented by a website quote-request channel and dedicated sales portal. The company sells capital equipment under multi-year contracts and disposable probes on a pay-as-you-go basis, with a customer base spanning reconstructive surgery, robotic-assisted surgery, urology, GI endoscopy, vascular surgery, and neurosurgery. In June 2025, VTI received a private equity investment from JLL Partners and appointed Greg Groenke as CEO and Lars Marcher as Executive Chairman; in November 2025, JLL Partners combined VTI with Parks Medical Electronics to create a broader medical device platform focused on vascular and robotics applications.

Name

Vascular Technology

Legal name

Vascular Technology, Incorporated

Website

https://vti-online.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Suction, Irrigation & Fluid Management Systems (HLAHADAK), Ultrasound & Echography Systems (HLAHABAD), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

Keywords

• Surgical Doppler systems
• Intraoperative blood flow monitoring
• Disposable Doppler probes
• Robotic suction irrigation
• Medical device manufacturing

Headquarters

HQ city

Nashua

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Doppler Systems Hardware Sales: VTI generates revenue from the sale of Doppler transceiver systems (both 8 MHz and 20 MHz variants) including the TQI, Microvascular, Selectable Depth, and Drop-In systems. These are capital equipment purchases for operating rooms.
2. Disposable Doppler Probes: Single-use, sterile Doppler probes sold in boxes (typically 4 per box) for various surgical applications. These are recurring consumable purchases as each probe is single-patient-use.
3. ROSI System Components: Sales of ROSI control units, tubing sets with exchangeable tips, power supplies, foot switches, and inflation cuffs for the robotic suction irrigation system.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

VTI designs, manufactures, and markets surgical Doppler ultrasound systems (8 MHz and 20 MHz variants) for real-time intraoperative blood flow assessment, complemented by single-use disposable Doppler probes. The portfolio also includes the ROSI (Remotely Operated Suction Irrigation) system that gives robotic surgeons console-level control of suction and irrigation. All products are manufactured in the U.S.A. under ISO 13485 and FDA registration for use across vascular, reconstructive, urology, GI endoscopy, neurosurgery, and robotic-assisted surgical specialties.

Product overview

VTI is a medical device company offering a portfolio of surgical Doppler systems and suction irrigation products. The core product line includes the TQI 2.0 (8 MHz), 20 MHz Microvascular, 20 MHz Selectable Depth, and Drop-In Doppler systems, along with the ROSI (Remotely Operated Suction Irrigation) system for robotic surgery. These systems are supported by a comprehensive range of sterile, single-use disposable Doppler probes designed for various surgical specialties including vascular surgery, reconstructive surgery, urology, GI endoscopy, neurosurgery, and robotic surgery. VTI serves operating rooms across multiple surgical specialties, with products proudly manufactured in the U.S.A.

Differentiator

Problem solved

Functional benefit

Products and services

• 8 MHz TQI 2.0 Trans-Q-Taneous Intraoperative Doppler System Multi-functional 8 MHz Doppler system with transcutaneous and intraoperative modes for real-time blood flow evaluation in reconstructive, vascular, and other surgical specialties. Compatible with sterile, single-use Doppler probes and features IV pole mount, transport handle, and optional foot pedal.
• 20 MHz Microvascular Doppler System

Quantifiable outcome

• Doppler-guided management significantly decreases 30-day rebleeding rates compared to standard of care in severe upper GI bleeding
• +5 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Parks Medical ElectronicscoreStrategic or Co-development Partner · 5 November 2025JLL Partners acquired Parks Medical Electronics and combined it with Vascular Technology Incorporated to create a leading medical device company focused on vascular and robotics applications. The combination aimed to strengthen the platform by offering a comprehensive portfolio of ultrasound and vascular diagnostic systems. Parks Medical Electronics brought additional diagnostic blood flow evaluation technology including the Flo-Lab Vascular system to the combined entity.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Parks Medical Electronics: Now combined with VTI under JLL Partners, Parks manufactures ultrasonic Doppler blood-flow detectors (Flo-Lab series) used in vascular diagnostics. It is the most direct peer — overlapping Doppler technology, vascular customer base, and hospital-channel GTM — and was recently folded into the same platform.
• Karl Storz: Global leader in endoscopy and minimally invasive surgical instruments with deep OR presence in urology, gynecology, and GI endoscopy — the same specialties VTI targets. Overlaps with VTI's endoscopic Doppler and ROSI product lines through integrated visualization and instrumentation platforms.
• Cook Medical: Privately held medical device manufacturer with a strong vascular and surgical-instruments portfolio. Comparable in scale and channel (direct hospital sales, physician-focused), and competes in vascular access and intraoperative imaging-adjacent categories.
• CONMED: Public medical device company focused on general surgery, orthopedic, and surgical-visualization products. Overlaps with VTI in suction/irrigation and minimally invasive surgical instrumentation sold to hospitals and ambulatory surgery centers.
• AngioDynamics: Medical device company focused on vascular access, peripheral vascular disease, and oncology. Comparable specialty distribution and similar scale, with overlapping hospital vascular-surgery customers and procedure-driven consumable economics.

Emerging players

• Penumbra: Vascular-focused medical device company with growing interventional and surgical portfolios. Competes for the same vascular-surgery hospital accounts and represents an emerging platform player expanding into adjacent intraoperative and robotic-compatible indications.

Broad incumbents

• Intuitive Surgical: Dominant robotic-surgery platform vendor whose installed base defines the addressable market for VTI's ROSI and Drop-In Doppler. Not a direct Doppler competitor, but the single most important ecosystem participant — its accessory and integration policies directly shape VTI's robotic-surgery opportunity.
• Stryker: Large diversified medical device incumbent with surgical-instruments, endoscopy, and capital-equipment franchises. Competes broadly in OR equipment and could bundle Doppler/irrigation functionality into its integrated surgical platforms.
• Medtronic: Global medtech leader with surgical, vascular, and GI endoscopy portfolios. Competes with VTI across multiple customer call points and represents a long-term bundling threat to standalone Doppler and irrigation players.
• B. Braun: Diversified medical device and pharmaceutical company with strong surgical-instruments and capital-equipment presence globally. Comparable in surgical-instruments and OR supply categories, with the scale to bundle competing products into broader hospital contracts.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vascular Technology